[go: up one dir, main page]

WO1999055162A8 - Method for the treatment of viral disease - Google Patents

Method for the treatment of viral disease

Info

Publication number
WO1999055162A8
WO1999055162A8 PCT/US1998/008291 US9808291W WO9955162A8 WO 1999055162 A8 WO1999055162 A8 WO 1999055162A8 US 9808291 W US9808291 W US 9808291W WO 9955162 A8 WO9955162 A8 WO 9955162A8
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
mammal
viral disease
virus
antispermatozoal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1998/008291
Other languages
French (fr)
Other versions
WO1999055162A1 (en
Inventor
T Ronald Theodore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to AU71575/98A priority Critical patent/AU7157598A/en
Priority to PCT/US1998/008291 priority patent/WO1999055162A1/en
Publication of WO1999055162A1 publication Critical patent/WO1999055162A1/en
Publication of WO1999055162A8 publication Critical patent/WO1999055162A8/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A method for the treatment of viral diseases, particularly that caused by AIDS virus, and more particularly HIV-1, in a mammal, which method comprises administering to the mammal having the virus a therapeutic, effective amount of a human antispermatozoal antibody, or monoclonal antibodies derived therefrom, used alone or in combination with plasma, serum or purified immunoglobulin, and combinations thereof.
PCT/US1998/008291 1998-04-24 1998-04-24 Method for the treatment of viral disease Ceased WO1999055162A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU71575/98A AU7157598A (en) 1998-04-24 1998-04-24 Method for the treatment of viral disease
PCT/US1998/008291 WO1999055162A1 (en) 1998-04-24 1998-04-24 Method for the treatment of viral disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/008291 WO1999055162A1 (en) 1998-04-24 1998-04-24 Method for the treatment of viral disease

Publications (2)

Publication Number Publication Date
WO1999055162A1 WO1999055162A1 (en) 1999-11-04
WO1999055162A8 true WO1999055162A8 (en) 2000-07-13

Family

ID=22266910

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/008291 Ceased WO1999055162A1 (en) 1998-04-24 1998-04-24 Method for the treatment of viral disease

Country Status (2)

Country Link
AU (1) AU7157598A (en)
WO (1) WO1999055162A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5759545A (en) * 1996-02-27 1998-06-02 Theodore; T. Ronald Method for the treatment of HIV-I infection

Also Published As

Publication number Publication date
AU7157598A (en) 1999-11-16
WO1999055162A1 (en) 1999-11-04

Similar Documents

Publication Publication Date Title
UY28170A1 (en) PREPARATION AND TREATMENT FOR DEMIELINIZING DISEASES AND PARALYSIS THROUGH THE APPLICATION OF REMIELINIZING AGENTS.
EP1127170A4 (en) HUMAN MONOCLONAL ANTIBODIES TO HUMAN PAN-HEPATITIS C VIRUS
HK1042708A1 (en) Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
FR12C0004I2 (en) ANTIBODIES TO HUMAN CTLA-4 ANTIGEN AND USE
DK1140170T3 (en) Antibody fragments for topical treatment of eye diseases
KR950005327A (en) Bispecific trigger molecules that recognize lymphocyte antigen CD2 and tumor antigen
WO2004018649A3 (en) Monoclonal antibodies and complementarity-determining regions binding to ebola glycoprotein
WO2004022718A3 (en) Therapeutic human anti-il-1r1 monoclonal antibody
DK0751781T3 (en) Use of monoclonal antibodies or soluble oligomeric ligands in the manufacture of a medicament for the prevention or treatment of neoplastic diseases
DE69636760D1 (en) RECOMBINANT ANTI-CD4 ANTIBODY FOR HUMAN TREATMENT
FI963101A7 (en) Use of anti-TNF antibodies as a drug for the treatment of diseases in which serum interleukin-6 levels are elevated
WO2003043583A3 (en) Treatment of immunological disorders using anti-cd30 antibodies
PL401886A1 (en) Neutralising, a high-affinity anti-TNF-alpha isolated human antibody, use of this antibody, crystal containing the anti-TNF-alpha human antibody and a preparation containing the crystal
UA111707C2 (en) APPLICATION OF SELECTED HUMAN ANTIBODY ANTI-TNF-ALPHA
WO2001058485A3 (en) Prophylactic and therapeutic antibodies against vaccina virus antigens
AU3045497A (en) Human monoclonal antibody against hepatitis b virus surface antigen (hbvsag)
DE69738138D1 (en) Induction of immunological tolerance to a therapeutic antibody by variants of the therapeutic antibody
EA200401081A1 (en) FAB FRAGMENTS OF THE MONOCLONAL HUMAN ANTIBODY, DIRECTED AGAINST GLYCOPROTEIN E2 HCV AND HAVING NEUTRALIZING ACTIVITY IN VITRO
WO2004108885A3 (en) Fc chimeric proteins with anti-hiv drugs
EA200400134A1 (en) THERAPEUTIC AGENT
PT1200126E (en) Use of cd28 specific monoclonal antibodies for producing a pharmaceutical composition for treating virus infections
DE69636527D1 (en) ANTIGENE PROTEIN FROM MALASSEZIA
DE60236853D1 (en) PHARMACEUTICAL COMPOSITION OF F (AB) 2-ANTIBODY FRAGMENTS AND METHOD FOR THE PRODUCTION THEREOF
CA2412460A1 (en) Human monoclonal antibody against hepatitis c virus e2 glycoprotein
WO1999055162A8 (en) Method for the treatment of viral disease

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA JP MX US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)

Free format text: (EXCEPT CN, IL, KR, NO, RU, SG)

AK Designated states

Kind code of ref document: C1

Designated state(s): AU CA CN IL JP KR MX NO RU SG US

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT. BUL. 44/99 UNDER (81) ADD "CN, IL, KR, NO, RU, SG"; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: CA